Presence and possible role of calcium-dependent regulator (calmodulin) in rat islets of langerhans  by Sugden, M.C. et al.
Volume 105, number 1 FEBSLETTERS September 1979 
PRESENCE AND POSSIBLE ROLE OF CALCIUM-DEPENDENT REGULATOR 
(CALMODULIN) IN RAT ISLETS OF LANGERHANS 
M. C. SUGDEN, M. R. CHRISTIE and S. J. H. ASHCROFT 
Department of Clinical Biochemistry, Radcliffe Infirmary, Oxford, OX2 6HE, England 
Received 29 June 1979 
1. Introduction 
A rise in the intracellular concentration of free 
Ca2+ has been implicated as a key event in the initia- 
tion of insulin secretion [ 1,2] but the mechanism by 
which Ca2+ triggers exocytosis is not known. In other 
Ca”-regulated processes, Ca2+ exerts a controlling 
influence by binding to specific proteins, e.g., 
troponin C in the initiation of muscle contraction, 
and phosphorylase kinase in the activation of glyco- 
genolysis [3,4]. On the basis of amino acid sequence 
and X-ray crystallographic data a family of 5 homolo- 
gous Ca”-modulated proteins: calcium dependent 
regulator (calmodulin); troponin C; myosin light 
chains; muscle pervalbumin; and intestinal calcium 
binding protein, has been described [S]. Binding of 
Ca2+ is suggested to depend on the presence of homol- 
ogous a-helical domains referred to as EF-hands [S]. 
Calmodulin may be of special significance as a general 
intracellular Ca’+-receptor protein in view both of its 
ubiquitous tissue distribution in eukaryotes and of 
the variety of proteins to which it confers sensitivity 
to Ca’+. Originally discovered [6] as a heat-stable 
protein activator of brain cyclic nucleotide phospho- 
diesterase (PDE), calmodulin has been shown inter alia 
to activate a detergent-solubilized preparation of 
brain adenylyl cyclase [7] and a Ca2’-ATPase in 
erythrocyte membranes [8] and to be a component 
Abbreviations: PDE, cyclic nucleotide phosphodiesterase 
(EC 3.1.4.1); cyclic AMP, cyclic adenosine-3’,5’-monophos- 
phate; EGTA, ethylene glycol bis @aminoethyl)tetraacetic 
acid 
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of phosphorylase kinase [9] and of myosin light 
chain kinase [lo] in skeletal muscle. In these studies 
we have investigated the hypothesis that calmodulin 
may play a role in Ca2’-dependent insulin secretion. 
Extracts of rat islets of Langerhans were shown to 
contain a heat-stable activator of brain PDE. Activa- 
tion was dependent on the presence of Ca2+ and was 
abolished by trifluoperazine, a specific inhibitor of 
calmodulin [ 111. Trifluoperazine also inhibited 
glucose-stimulated insulin release but not islet glucose 
oxidation. These findings demonstrate the presence 
of calmodulin in islets of Langerhans and suggest its 
possible involvement in stimulus-secretion coupling 
in the o-cell. 
2. Materials and methods 
2.1. Reagents 
Bovine albumin (fraction V), 5’-nucleotidase and 
collagenase (type I) were obtained from Sigma 
(London) Chemical Co. Cyclic AMP was from the 
Boehringer Corp. (London) Ltd. (12’I)Insulin, 
cyclic [8-3H] AMP and [U-‘4C]glucose were from 
the Radiochemical Centre, Amersham. QAE- 
Sephadex was from Pharmacia (GB) Ltd. Guinea pig 
anti-porcine insulin serum was obtained from Well- 
come Reagents Ltd. All other chemicals were from 
BDH Chemicals and were of the highest purity avail- 
able. Trifluoperazine (Stelazine) was a gift from 
Smith, Kline and French Labs. 
Calmodulin prepared from phosphorylase kinase 
[9,12] was a generous gift from Dr P. Cohen (Depart- 
ment of Biochemistry, University of Dundee). Cal- 
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modulin-deficient phosphodiesterase, prepared from 
bovine brain cortices by the method in [i 31, was a 
gift from Dr P. H. Sugden (Department of Clinical 
Biochemistry, University of Oxford). 
2.2. Preparation of islets 
Islets were prepared using collagenase digestion 
(141 from the pancreases of 200-300 g male albino 
Wistar rats fed ad libitum on a standard laboratory 
diet. 
2.3. Output of 14C02 
The rate of formation of 14C02 from [U-r4C]glucose 
was measured as in [ 151. 
2.4, Insulin release 
Batches of islets were incubated in vitro for 2 h 
and insulin release measured as in [ 16,171. Radio- 
imnlunoassay of insulin was performed as in [ 17] 
except that Wellcome guinea pig anti-insulin serum 
was used as antibody. 
2 5. Assay of phosphodiesterase 
PDE assays were performed in IO0 ~1 final vol. 
containing 50 mM Tris-HCI, (pH 8.0), 3 mM MgC&, 
0.1 mg bovine ~lbunl~n~rlll, cyclic [3H] AMP (30 Ci/ 
mmol; -1 X lo6 dpm) and unlabelled cyclic AMP at 
0.1 mM final cont. Activator-dependent activity was 
measured in the presence of 0.05 mM CaClz and 
appropriate amounts of calmodulin or islet extracts. 
Tubes were i~~cubated for 1.5 min at 30°C and the 
reaction terminated by placing the tubes in a boiling 
water-bath for 2 min. In all experiments the amount 
of enzyme caused hydrolysis of < 35% of the sub- 
strate. 2 ~1 snake venom 5’nucleotidase (50 units/ml) 
were added to each tube. The tubes were then 
incubated for 15 min at 3O*C and the reaction termi- 
nated by boiiing as above. 0.4 ml 0.1 mM adenosine 
in 20 mM ammonium formate (pH 7.5) were added 
to each tube. Tritiated adenosine was separated from 
unreacted cyclic AMP by passing the contents of each 
tube over a column (0.5 X 1 .O cm) of quaternary 
aminoet~ly~ (QAE)-Sephadex (A-25) in the formate 
form. The tubes were rinsed with 1.5 ml 20 mM 
ammonium formate (pH 7.5) which was also passed 
over the column. The effluent (2.0 ml) was collected 
and 0.8 ml aliquots counted in 18 ml methoxyethanol 
scintiilation fluid 1181. 
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2 6. Preparation of islet extracts for assay of calmodulin 
Islets were placed into 10 mM Tris-MCI, (pH 8.0) 
and disrupted by sonication with three intervals of 5 s 
at position 2 on a Dawe Soniprobe. Islet sonicates 
were diluted with 10 mM Tris-HCl (pH 8.0) to a 
concentration equivalent to-O.25 islets/PI and placed 
in a boiling water bath for 3 min. This procedure was 
found to conlpleteiy inactivate islet phosphodiesterase. 
The boiled samples were centrifuged for 15 s in an 
Eppendorf 3200 centrifuge and S--50 ~1 aliquots of 
the supernatants assayed for calmodulin activity by 
activation of PDE. 
3. Results 
3.1. Assa.y of calmodulin 
In these experiments PDE activity was measured 
as the formation of ]3H]adenosine from cyclic 3’,5’- 
[3H]AMP according to the equation: 
Cyclic 3’,5’-AMP --E+ 5’-AMP 
5~-nuc~eotidase~ adenosine __ 
Conditions were chosen such that the time course of 
[3H]adenosine formation was linear and the rate was 
proportional to the concentration of PDE. The 
activity of a fixed amount of calmodulin-free PDE 
(4 X 10T5 units) was increased by the addition of 
L-100 ng calmodulin; a typical activation curve is 
shown in fig.1. Half-maximal activation required 
10 ng calmodulin. The mean maximal activation was 
-6-fold. Activation of PDE by calmodulin required 
the presence of Cd2+; in the absence of added Ca’+ 
and with EGTA present to chelate traces of Ca’+ in 
the reagents, calmodulin did not stimulate PDE 
(fig.1). Trifluoperazine has been shown to bind to 
brain calmodulin [ 111. The effects of increasing con- 
centrations of trifluoperazine on the activation of 
PDE by 20 ng calmodulin are shown in fig.2.60 I.IM 
trifluoperazine lowered PDE activity to values seen in 
the absence of calmodulin. Half-maximal inhibition 
under these conditions required 12 PM trifluopera- 
zine. 
These observations form the basis for the criteria 
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Fig.1. The Ca”dependent activation of PDE by calmodulin. 
PDE activity was measured in the presence of varying 
amounts of calmodulin. Results are expressed as a percentage 
of the PDE activity in controls with no added calmodulin 
(37 pmol/min). The closed circles refer to assays conducted 
in the presence of Ca’+ (SO wM) and the open circles are 
values obtained in the absence of added CaZC and the presence 
of EGTA (1 mM). 
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Fig.2. Effect of trifluoperazine on calmodulin-activated Fig.3. Activation of PDE by islet extracts. The effect of 
PDE. The activity of PDE stimulated by 20 ng calmodulin varying amounts of islet extract equivalent to the number 
was measured in the presence of varying concentrations of of islets shown was tested on the activity of PDE as described 
trifluoperazine. The PDE activity is expressed as a percentage in section 2. The PDE activity is expressed as a percentage 
of its value in the absence of tritluoperazine (147 pmol/ of its value in the absence of added extract (42 pmol/min). 
min). The dotted line indicates the activity of PDE in the The results are the mean values for 3 separate preparations 
absence of calmodulin. of islet extract. 
used to demonstrate the presence of calmodulin in 
rat islets of Langerhans, viz.: 
(i) The activation of PDE by extracts of rat islets; 
(ii) The stability of the activating factor to boiling; 
(iii) The dependence of activation on the presence 
of Ca*+; 
(iv) Abolition of activation by trifluoperazine. 
3.2. Calmodulin in extracts of rat islets of Langerhans 
Extracts of rat islets prepared by sonication were 
boiled for 3 min and tested for their ability to activate 
brain PDE. Activation occurred (fig.3) to a maximum 
extent of 6-fold, i.e., equivalent to the maximum 
activation achieved with authentic calmodulin. Islet 
calmodulin was measured by using amounts of islet 
extract that gave sub-maximal activation of PDE. Islet 
calmodulin content could thus be quantitated by 
comparison with standard curves for PDE activation 
constructed using authentic calmodulin which were 
included in each experiment. The calculated amounts 
of calmodulin measured in this way were linearly 
related to the amount of islet extract assayed (fig.4). 
A mean value for 9 separate preparations of islets of 
1.8 + 0.2 ng calmodulin/islet was found. Assuming a 
mean intracellular volume of 3 nl/islet [19] and 
calmodulin mol. wt 16 700 [9], this corresponds to a 
mean of 36 I.~M calmodulin. 
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Fig.4. Islet content of calmodulin. Aliquots of islet extract 
corresponding to 2.5 15 islets were assayed for their ability 
to activate PDE. The islet content of calmodulin was calculated 
from PDE-activation curves using authentic calmodulin. The 
results are the mean values for 3 separate preparaiions of islet 
extract. 
Activation of PDE by islet extract was totally 
dependent on addition of Ca’+: three separate prepara- 
tions of islet extract producing a mean activation of 
PDE of 2.4-fold in the presence of Ca*+ elicited no 
significant stimulation in the absence of Ca2+ and in 
the presence of EGTA (93 + 4% of control activity in 
the absence of extract). 
The lowest concentration of trifluoperazine that 
completely prevented activation of PDE by authentic 
calmodulin was tested on the activation of PDE by 
varying amounts of islet extract containing G 25 ng 
calmodulin. Figure 5 shows that 60 /..LM trifluopera- 
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Fig.5. Inhibition by trilluoperazine of PDE activated by islet 
extract. Varying amounts of islet extract were assayed for 
their ability to activate PDE. The calmodulin in the extracts 
was quantified using PDE-activation curves with authentic 
calmodulin. The closed symbols refer to assays conducted in 
the absence of trifluoperazine and the open symbols to 
assays in which 60 PM trifluoperazine was included. Each 
symbol-type refers to a separate experiment with one islet 
extract and standard curve. 
zine abolished the activation of PDE by varying 
amounts of islet extract containing G 25 ng 
calmodulin. Trifluoperazine did not reduce the basal 
PDE activity observed in the absence of Ca’+. 
3.3. Effects of trijluoperazine 012 intact islets 
Results are given in table 1. 
Insulin release stimulated by 20 mM glucose was 
-50% inhibited by 25 ,uM trifluoperazine but basal 
Table 1 
Effects of trifluoperazine on glucose-stimulated insulin release and [U-“‘Clglucose oxidatibn by isolated islets 
Parameter 
Insulin release 
[U-‘4C]Glucose 
Units Glucose Trifluoperazine (PM) 
20 mM 
0 25 50 
___ 
PU .islet“ .h-’ _ 31 + 3(44) 28 + 4 (10) 108 i- 16 (9)a 
+ 222 ? 17 (45) 132 * 25 (15)a 125 * 14 (44)b 
‘3C0, pmol .islet-’ .h-’ + 40 + 3 (8) 36 f 3 (8) 44 + 4 (7) 
a P G 0.01 
b P Q 0.001 
Batches of S-10 islets were incubated at 37°C for 2 h in Krebs bicarbonate medium containing albumin (2 mg/ml) and the addi- 
tions shown. Insulin release was determined by radioimmunoassay and the formation of 14C0, from [UJ4C]glucose (3 mCi/mmol) 
by liquid scintillation spectrometry. Results are given as mean * SEM for the number of batches of islets stated in parenthesis. 
The significance of differences from the controls (no trifluoperazine) was assessed by Student’s t-test 
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release was not affected. In the presence of 50 PM tri- 
fluoperazine basal release was enhanced but no 
stimulation by 20 mM glucose was observed. Since 
glucose-stimulated release is dependent on the ability 
of the islets to metabolize the sugar [20], the effect 
of trifluoperazine on the rate of oxidation of [U-r4C]- 
glucose by isolated islets was also tested. Neither 
25 PM nor 50 PM trifluoperazine affected the rate of 
oxidation of 20 mM glucose. 
4. Discussion 
These studies demonstrate that rat pancreatic islets 
contain a heat-stable activator of brain cyclic nucleo- 
tidephosphodiesterase. Activationisdependent on the 
presence of Ca*+ and is abolished by tritluoperazine. 
The maximum activation is similar to that observed 
with muscle calmodulin. The findings constitute 
strong evidence for the existence of calmodulin in 
rat pancreatic islets. The amount of calmodulin 
measured in islet extracts is 300-450 mg/kg wet 
tissue (assuming 5-6 /lg mean islet wet wt). This is 
close to the value reported for rabbit skeletal muscle 
[21] but considerably higher than that found in 
several other tissues tested [21]. 
Glucose-stimulated insulin release was impaired 
by a low concentration (25 PM) of trifluoperazine 
that did not affect islet glucose oxidation. This find- 
ing is consistant with the hypothesis that cahnodulin 
may play a role in stimulus-section coupling in the 
P-cell. Interpretation of the results obtained with 
50 FM trifluoperazine is more difficult since although 
the response to glucose was abolished, basal release 
was elevated. The possible nature of the involvement 
of calmodulin in insulin release is not known but con- 
sideration of the function of calmodulin in other 
systems raises several possibilities. For example the 
activation of both adenylyl cyclase and PDE by 
calmodulin might implicate the participation of 
calmodulin in the Ca”-dependent regulation of islet 
cyclic nucleotide concentrations: activation of 
adenylyl cyclase at the cell membrane by Ca*+- 
calmodulin followed by activation of PDE as Ca*+ 
diffuses into the cytosol could underlie the transient, 
Ca*‘-dependent increase in islet cyclic AMP observed 
in islets exposed to glucose [22]. However evidence 
has been presented that cyclic AMP acts as a poten- 
tiator rather than a direct trigger for glucose-induced 
insulin release [23] and thus alternative or additional 
roles of calmodulin are likely. 
Several studies have implicated a role for micro- 
tubules in the cxocytotic discharge of insulin [24-261; 
it is therefore relevant to note that, in rat brain, 
evidence has been presented that calcium regulates 
the assembly -disassembly of microtubules through 
the action of calmodulin [27]. Regulation of mem- 
brane ion fluxes is a further plausible function in 
exocytosis. Calmodulin has been shown to stimulate 
a Ca*‘-ATPase in erythrocyte membranes [8] and 
ATP-dependent Ca*+-transport in dog cardiac sarco- 
plasmic reticulum [28]. Furthermore, calmodulin 
influences Ca*‘-dependent anion flux across rabbit 
ileum [29]. Finally it has been demonstrated that 
calmodulin mediates Ca*‘-dependent protein phos- 
phorylation in membranes from various tissues [30]. 
Since Ca*‘-dependent protein phosphorylation has 
been demonstrated in mast cells stimulated with the 
Ca*‘-ionophore A23 187 [3 1 ] it is tempting to 
speculate that phosphorylation events may partici- 
pate in the membrane-membrane interactions 
involved in exocytosis. The cyclic AMP-indepen- 
dent protein phosphorylating activity recently demon- 
strated in rat pancreatic islets [32] may constitute 
a possible locus of action for islet calmodulin. Inves- 
tigation of the effects of Ca*+ and calmodulin on this 
activity could substantiate such a hypothesis. 
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